669 related articles for article (PubMed ID: 1664760)
1. The effects of sham and full spinalization on the systemic potency of mu- and kappa-opioids on spinal nociceptive reflexes in rats.
Herrero JF; Headley PM
Br J Pharmacol; 1991 Sep; 104(1):166-70. PubMed ID: 1664760
[TBL] [Abstract][Full Text] [Related]
2. Spinal antinociceptive actions and naloxone reversibility of intravenous mu- and kappa-opioids in spinalized rats: potency mismatch with values reported for spinal administration.
Parsons CG; West DC; Headley PM
Br J Pharmacol; 1989 Oct; 98(2):533-43. PubMed ID: 2555012
[TBL] [Abstract][Full Text] [Related]
3. Effects of intravenous mu and kappa opioid receptor agonists on sensory responses of convergent neurones in the dorsal horn of spinalized rats.
Dong XW; Parsons CG; Headley PM
Br J Pharmacol; 1991 May; 103(1):1230-6. PubMed ID: 1652344
[TBL] [Abstract][Full Text] [Related]
4. Spinal antinociceptive actions of mu- and kappa-opioids: the importance of stimulus intensity in determining 'selectivity' between reflexes to different modalities of noxious stimulus.
Parsons CG; Headley PM
Br J Pharmacol; 1989 Oct; 98(2):523-32. PubMed ID: 2555011
[TBL] [Abstract][Full Text] [Related]
5. Similar actions of kappa and mu agonists on spinal nociceptive reflexes in rats and their reversibility by naloxone.
Parsons CG; West DC; Headley PM
NIDA Res Monogr; 1986; 75():461-4. PubMed ID: 2828992
[TBL] [Abstract][Full Text] [Related]
6. On the selectivity of intravenous mu- and kappa-opioids between nociceptive and non-nociceptive reflexes in the spinalized rat.
Parsons CG; Headley PM
Br J Pharmacol; 1989 Oct; 98(2):544-51. PubMed ID: 2555013
[TBL] [Abstract][Full Text] [Related]
7. Functional evidence for multiple receptor activation by kappa-ligands in the inhibition of spinal nociceptive reflexes in the rat.
Herrero JF; Headley PM
Br J Pharmacol; 1993 Sep; 110(1):303-9. PubMed ID: 8220893
[TBL] [Abstract][Full Text] [Related]
8. Stimulus intensity and the comparative efficacy of mu- and kappa-opioid agonists on nociceptive spinal reflexes in the rat.
Thorn SA; Herrero JF; Headley PM
Brain Res; 1994 Nov; 663(2):352-6. PubMed ID: 7874523
[TBL] [Abstract][Full Text] [Related]
9. Kappa-opioid receptor-mediated antinociception in the rat. II. Supraspinal in addition to spinal sites of action.
Millan MJ; Członkowski A; Lipkowski A; Herz A
J Pharmacol Exp Ther; 1989 Oct; 251(1):342-50. PubMed ID: 2571723
[TBL] [Abstract][Full Text] [Related]
10. Discriminative stimulus properties of U50,488 and morphine: effects of training dose on stimulus substitution patterns produced by mu and kappa opioid agonists.
Picker MJ; Doty P; Negus SS; Mattox SR; Dykstra LA
J Pharmacol Exp Ther; 1990 Jul; 254(1):13-22. PubMed ID: 2164087
[TBL] [Abstract][Full Text] [Related]
11. [The effect of mu-, delta- and kappa-opiate receptor agonists on the bioelectrical activity of the viscerosomatic convergent neurons in the posterior horn of the spinal cord].
Kasparov SA
Eksp Klin Farmakol; 1993; 56(1):13-6. PubMed ID: 8391888
[TBL] [Abstract][Full Text] [Related]
12. Cross-tolerance to acute administration of mu and kappa opioid agonists at the spinal cord level in the rat.
Laurido C; Hernandez A; Perez H
Int J Neurosci; 1996 Nov; 87(3-4):191-9. PubMed ID: 9003979
[TBL] [Abstract][Full Text] [Related]
13. Sufentanil, morphine, met-enkephalin, and kappa-agonist (U-50,488H) inhibit substance P release from primary sensory neurons: a model for presynaptic spinal opioid actions.
Chang HM; Berde CB; Holz GG; Steward GF; Kream RM
Anesthesiology; 1989 Apr; 70(4):672-7. PubMed ID: 2467589
[TBL] [Abstract][Full Text] [Related]
14. Role of vagal afferents in the antinociception produced by morphine and U-50,488H in the colonic pain reflex in rats.
Diop L; Rivière PJ; Pascaud X; Dassaud M; Junien JL
Eur J Pharmacol; 1994 May; 257(1-2):181-7. PubMed ID: 8082700
[TBL] [Abstract][Full Text] [Related]
15. Discriminative stimulus effects of mu and kappa opioids in the pigeon: analysis of the effects of full and partial mu and kappa agonists.
Picker MJ; Dykstra LA
J Pharmacol Exp Ther; 1989 May; 249(2):557-66. PubMed ID: 2566680
[TBL] [Abstract][Full Text] [Related]
16. Effect of mu and kappa opioid receptor agonists on rat plasma corticosterone levels.
Hayes AG; Stewart BR
Eur J Pharmacol; 1985 Oct; 116(1-2):75-9. PubMed ID: 2996912
[TBL] [Abstract][Full Text] [Related]
17. Peripheral kappa-opioid receptors mediate the antinociceptive effect of fedotozine (correction of fetodozine) on the duodenal pain reflex inrat.
Diop L; Rivière PJ; Pascaud X; Junien JL
Eur J Pharmacol; 1994 Dec; 271(1):65-71. PubMed ID: 7698213
[TBL] [Abstract][Full Text] [Related]
18. Effects of selective and non-selective kappa-opioid receptor agonists on cutaneous C-fibre-evoked responses of rat dorsal horn neurones.
Knox RJ; Dickenson AH
Brain Res; 1987 Jul; 415(1):21-9. PubMed ID: 2887243
[TBL] [Abstract][Full Text] [Related]
19. Differential cross-tolerance to mu and kappa opioid agonists in morphine-tolerant rats responding under a schedule of food presentation.
Picker MJ; Negus SS; Powell KR
Psychopharmacology (Berl); 1991; 103(1):129-35. PubMed ID: 1848712
[TBL] [Abstract][Full Text] [Related]
20. Role of spinal kappa opioid receptors in the blockade of the development of antinociceptive tolerance to morphine.
Takahashi M; Senda T; Kaneto H
Eur J Pharmacol; 1991 Aug; 200(2-3):293-7. PubMed ID: 1664330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
